In chronic cholestasis, genetic testing is advised after excluding primary biliary cholangitis (PBC) through auto-antibody testing and primary sclerosing cholangitis (PSC) via MRCP, as well as in atypical autoimmune liver diseases such as AMA/ANA-negative PBC or small-duct PSC. Here, BTG3 is linked to sclerosing cholangitis.